Analyst Ratings for Coherus Biosciences (CHRS) [Sells]
CHRS Rating Summary
CHRS Price Target Summary
- Highest: $14.00 (Citi)
- Lowest: $7.00 (Barclays)
- Average: $8.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.75 (+353.4%)
* Over Last 12-Mos
Rating Score: 7.5 / 10 Percentile Rank: 80%
Rating Score: 7.5 / 10 Percentile Rank: 80%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|